SEC Company Response from SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478) (SLS) — Jun 26, 2018
SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478)
Date: June 26, 2018 · CIK: 0001390478 · Accession: 0001193125-18-203106
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225140
Letter
Acceleration Request
SELLAS Life Sciences Group, Inc.
315 Madison Avenue, 4th Floor
New York, NY 10017
VIA EDGAR
June 26, 2018
Ms. Irene Paik
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: SELLAS Life Sciences Group, Inc.
Registration Statement on Form S-1
File No. 333-225140
Request for Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), SELLAS Life Sciences Group, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 27, 2018, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective at some other time.
In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Cooley LLP, by calling Yvan-Claude Pierre of Cooley LLP at (212) 479-6721 or Marianne Sarrazin of Cooley LLP at (415) 693-2157.
If you have any questions regarding this request, please contact Yvan-Claude Pierre of Cooley LLP at (212) 479-6721 or Marianne Sarrazin of Cooley LLP at (415) 693-2157. Thank you for your assistance with this matter.
Sincerely,
SELLAS LIFE SCIENCES GROUP, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request SELLAS Life Sciences Group, Inc. 315 Madison Avenue, 4th Floor New York, NY 10017 VIA EDGAR June 26, 2018 Ms. Irene Paik Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: SELLAS Life Sciences Group, Inc. Registration Statement on Form S-1 File No. 333-225140 Request for Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), SELLAS Life Sciences Group, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 27, 2018, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Cooley LLP, by calling Yvan-Claude Pierre of Cooley LLP at (212) 479-6721 or Marianne Sarrazin of Cooley LLP at (415) 693-2157. If you have any questions regarding this request, please contact Yvan-Claude Pierre of Cooley LLP at (212) 479-6721 or Marianne Sarrazin of Cooley LLP at (415) 693-2157. Thank you for your assistance with this matter. Sincerely, SELLAS LIFE SCIENCES GROUP, INC. /s/ Angelos M. Stergiou Angelos M. Stergiou President and Chief Executive Officer cc: Gene Mack, SELLAS Life Sciences Group, Inc. Barbara A. Wood, SELLAS Life Sciences Group, Inc. Yvan-Claude Pierre, Cooley LLP Marianne Sarrazin, Cooley LLP